Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,750 | 1,271 | 89.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,125 | 1 | 8.0% |
| Consulting Fee | $562.50 | 1 | 2.1% |
| Education | $225.91 | 4 | 0.8% |
| Travel and Lodging | $16.46 | 1 | 0.1% |
| Long term medical supply or device loan | $16.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,760 | 241 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,092 | 172 | $0 (2024) |
| Janssen Biotech, Inc. | $2,778 | 107 | $0 (2024) |
| Celgene Corporation | $2,008 | 116 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,806 | 78 | $0 (2024) |
| QOL Medical, LLC | $1,328 | 61 | $0 (2024) |
| PFIZER INC. | $1,251 | 80 | $0 (2024) |
| Merck Sharp & Dohme LLC | $895.61 | 47 | $0 (2024) |
| UCB, Inc. | $854.26 | 70 | $0 (2020) |
| Allergan, Inc. | $764.95 | 39 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,972 | 190 | Janssen Biotech, Inc. ($612.45) |
| 2023 | $3,680 | 211 | AbbVie Inc. ($826.37) |
| 2022 | $4,142 | 222 | ABBVIE INC. ($826.40) |
| 2021 | $3,209 | 122 | Janssen Biotech, Inc. ($762.82) |
| 2020 | $1,278 | 61 | AbbVie Inc. ($325.77) |
| 2019 | $2,758 | 155 | AbbVie, Inc. ($521.29) |
| 2018 | $2,778 | 170 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($513.69) |
| 2017 | $4,880 | 148 | AbbVie, Inc. ($2,665) |
All Payment Transactions
1,279 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Immunology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $40.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: GI | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Immunology | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: GI | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 509 | 613 | $493,895 | $61,374 |
| 2022 | 9 | 459 | 538 | $431,845 | $54,136 |
| 2021 | 11 | 475 | 571 | $270,110 | $51,873 |
| 2020 | 8 | 379 | 480 | $196,765 | $34,906 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 239 | $89,625 | $18,543 | 20.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 48 | 50 | $105,000 | $11,562 | 11.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 102 | 102 | $45,900 | $9,260 | 20.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $100,450 | $5,708 | 5.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $52,500 | $4,556 | 8.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 40 | $72,000 | $4,081 | 5.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $13,500 | $3,773 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 33 | $13,200 | $3,538 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 43 | $1,720 | $353.70 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 214 | $72,495 | $16,063 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 95 | 95 | $41,250 | $8,302 | 20.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 35 | 35 | $71,850 | $8,239 | 11.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $55,100 | $5,548 | 10.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 44 | 44 | $86,600 | $4,825 | 5.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 44 | 46 | $82,200 | $4,774 | 5.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $12,250 | $3,833 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 23 | $9,200 | $2,483 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 24 | $900.00 | $68.29 | 7.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 165 | 244 | $34,160 | $19,189 | 56.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 33 | 33 | $51,150 | $7,556 | 14.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 52 | 56 | $67,200 | $5,980 | 8.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $15,000 | $4,884 | 32.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $10,500 | $4,271 | 40.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 40 | 40 | $58,000 | $4,198 | 7.2% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 18 | 19 | $24,700 | $2,776 | 11.2% |
About Dr. Anthony Weiss, MD
Dr. Anthony Weiss, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962430488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Weiss, MD has received a total of $26,696 in payments from pharmaceutical and medical device companies, with $3,972 received in 2024. These payments were reported across 1,279 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($23,750).
As a Medicare-enrolled provider, Weiss has provided services to 1,822 Medicare beneficiaries, totaling 2,202 services with total Medicare billing of $202,288. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 06/30/2006
- Last Updated 05/27/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962430488
Products in Payments
- XIFAXAN (Drug) $2,492
- STELARA (Biological) $2,318
- ZEPOSIA (Drug) $2,137
- Humira (Biological) $1,286
- ENTYVIO (Biological) $1,189
- XELJANZ (Drug) $1,126
- LINZESS (Drug) $1,022
- Cimzia (Drug) $854.26
- HUMIRA (Biological) $808.02
- DIFICID (Drug) $771.44
- SUCRAID (Drug) $757.38
- RINVOQ (Biological) $726.67
- Entyvio (Biological) $723.15
- Sucraid (Drug) $570.48
- SKYRIZI (Biological) $565.87
- TRULANCE (Drug) $466.55
- CREON (Drug) $415.68
- ZENPEP (Drug) $404.19
- DUPIXENT (Biological) $364.43
- GATTEX (Drug) $314.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554